Veolia

Gain valuable insights on how to conquer the significant obstacles faced during the production of hot water for injection and pure steam

https://www.pharmtech.com/pt_w/mitigating-production-risk

Attend this webinar to gain valuable insights on how to conquer the significant obstacles faced by pharmaceutical and biotech companies during the production of hot water for injection and pure steam, all while staying true to sustainability goals. Learn about the improved Polaris™ 2.0 range, by Veolia Water Technologies, which includes the Multiple Effect Distiller (MED) for the production of hot water for injection and the Pure Steam Generator (PSG) for the production of pure steam.
These cutting-edge technologies have been designed to address the specific demands of the pharmaceutical industry, offering unparalleled reliability, efficiency, and quality. Not only do these solutions optimize production processes for hot water and pure steam, but also minimize environmental impact by reducing the consumption of industrial steam and energy.

How Veolia Water Technologies supports pharmaceutical industries

The recent improvements made to the Polaris range

The importance of an improved maintainability of the units

Meeting sustainability goals within the pharmaceutical industry

10.35am CET - Veolia Water Technologies capabilities in the Pharmaceutical Market

10.45am CET - Pure fluids risk management with hot water for injection and pure steam

11.05am CET - The Importance of a Service Partner

11.15am CET - How to meet your pharmaceutical sustainability goals


Polaris Product Manager
Veolia Water Technologies




Proposal Engineer Pharmaceutical
Veolia Water Technologies




Business Development Manager- Pharmaceutical
Veolia Water Technologies




European Solutions Manager- Pharma & Cosmetics
Veolia Water Technologies


Webcasts

Webinar Date/Time: Wed, Feb 7, 2024 10:30 AM CET (4:30 AM EST)





Veolia

Articles